Not interested in pharma stocks lik Wockhardt and Ranbaxy: Mehraboon Irani

In a chat with ET Now, Mehraboon Irani, Principal & Head-Private Client Group Business, Nirmal Bang Securities shares his view on pharma stocks like Wockhardt and Ranbaxy.

ET Now: What would you do with the pharma companies like Wockhardt and Ranbaxy?

Mehraboon Irani: I have seen the markets for 20 years. Whenever we have a sharp rally, it is always the stocks which have been beaten down the most rebound the sharpest.

Now, if you buy into that rebound and make quick money as a trader, it is fine. But, as long as there is uncertainty, the people who buy for the longer term will come and touch the stock. Honestly, I also would not be interested.

From a rebound angle for an investor/trader who wants to take some risk, there could be money on the table.

There are a whole lot of options available in the market where you can possibly participate in the street and make money. One doesn't want to go across the names which have scars on them right now.